Document is current

Any future updates will be listed below

Correction: Matching-Adjusted Indirect Comparison of the Efficacy at Week 32 of Tralokinumab and Dupilumab in the Treatment of Moderate-to-Severe Atopic Dermatitis

Crossref DOI link: https://doi.org/10.1007/s13555-024-01315-9

Published Online: 2025-01-17

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark